US Stock MarketDetailed Quotes

GERN Geron

Watchlist
  • 2.560
  • -0.230-8.24%
Close Feb 14 16:00 ET
  • 2.580
  • +0.020+0.78%
Post 19:59 ET
1.55BMarket Cap-8.00P/E (TTM)

About Geron Company

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.

Company Profile

SymbolGERN
Company NameGeron
Listing DateJul 30, 1996
Issue Price8.00
Founded1990
CEODr. John A. Scarlett,M.D.
MarketNASDAQ
Employees141
Fiscal Year Ends12-31
Address919 East Hillsdale Boulevard,Suite 250
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-473-7700

Company Executives

  • Name
  • Position
  • Salary
  • Dr. John A. Scarlett,M.D.
  • Chairman of the Board, Chief Executive Officer and President
  • 4.92M
  • Shannon T. Odam
  • Senior Vice President and Chief People Officer
  • --
  • Edward E. Koval
  • Executive Vice President and Chief Business Officer
  • --
  • Michelle Robertson
  • Executive Vice President, Finance, Chief Financial Officer, Principal Accounting Officer and Treasurer
  • 2.47M
  • Scott A. Samuels
  • Executive Vice President, Chief Legal Officer and Corporate Secretary
  • 3.61M
  • Anil Kapur
  • Executive Vice President, Corporate Strategy and Chief Commercial Officer
  • --
  • Dr. Andrew J. Grethlein,PhD
  • Executive Vice President and Chief Operating Officer
  • 2.42M
  • Melissa A. Kelly Behrs
  • Executive Vice President, Business Operations and Chief Alliance Officer
  • --
  • Dr. Faye Feller
  • Executive Vice President and Chief Medical Officer
  • --
  • Dr. Susan M. Molineaux, PhD
  • Independent Director
  • 345.90K
  • Dr. Gaurav Aggarwal, M.D.
  • Independent Director
  • 290.82K
  • John F. McDonald
  • Independent Director
  • 348.40K
  • Dr. V. Bryan Lawlis, PhD
  • Independent Director
  • 360.90K
  • Elizabeth G. O’Farrell
  • Lead Independent Director
  • 375.53K
  • Dr. Robert J. Spiegel, F.A.C.P.,M.D.
  • Independent Director
  • 350.90K
  • Dawn Carter Bir
  • Independent Director
  • 343.12K

Trending Stocks

Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More